Inventor · disambiguated record
Tobias Wunberg
Also filed as: WUNBERG TOBIAS
23 granted patents·12 pending applications·104 citations·filing 1998–2024
94Inventor score
Files withBOEHRINGER INGELHEIM INT14BAYER SCHERING PHARMA AG4AICURIS GMBH & CO KG3WUNBERG TOBIAS3BAYER HEALTHCARE AG2
Top patents by PatentIndex Score
35 records- 0190US10829487B2Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Nov 10, 2020·5 cites·65 claims
- 0288US10898487B2Benzylamino substituted quinazolines and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jan 26, 2021·8 cites·19 claims
- 0387US8513255B2Substituted dihydroquinazolinesWUNBERG TOBIAS·Filed 2007·Granted Aug 20, 2013·9 cites·13 claims
- 0487US7196086B2Substituted dihydroquinazolinesBAYER HEALTHCARE AG·Filed 2004·Granted Mar 27, 2007·24 cites·19 claims
- 0585US10138251B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Nov 27, 2018·6 cites·12 claims
- 0683US12053473B2Benzylamino substituted quinazolines and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Aug 6, 2024·1 cites·5 claims
- 0782USRE46791ESubstituted dihydroquinazolinesAICURIS GMBH & CO KG·Filed 2015·Granted Apr 17, 2018·3 cites·44 claims
- 0879US8198282B2Substituted azaquinazolines having an antiviral actionWUNBERG TOBIAS·Filed 2009·Granted Jun 12, 2012·2 cites·4 claims
- 0978US7662822B2Substituted azaquinazolines having an antiviral actionBAYER SCHERING PHARMA AG·Filed 2005·Granted Feb 16, 2010·3 cites·5 claims
- 1075US8318761B2Substituted arylsulfonamides as antiviral agentsSVENSTRUP NIELS·Filed 2008·Granted Nov 27, 2012·5 cites·8 claims
- 1171US7960387B22-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegalovirusesBAYER SCHERING PHARMA AG·Filed 2004·Granted Jun 14, 2011·5 cites·4 claims
- 1270USRE49698ESubstituted dihydroquinazolinesAICURIS ANTI INFECTIVE CURES GMBH·Filed 2020·Granted Oct 17, 2023·0 cites·27 claims
- 1370US2024358688A1Substituted 1h-pyrazolo[4,3-c]pyridines and derivatives as egfr inhibitorsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1469US7709491B2Substituted quinazolines as antiviral agents, especially against cytomegalovirusesBAYER SCHERING PHARMA AG·Filed 2003·Granted May 4, 2010·4 cites·15 claims
- 1568US8314113B2Substituted dihydroquinazolines IIWUNBERG TOBIAS·Filed 2004·Granted Nov 20, 2012·4 cites·10 claims
- 1668US7115612B2Arylsulfonamides as antiviral agentsBAYER AG·Filed 2002·Granted Oct 3, 2006·5 cites·20 claims
- 1767US7115636B2Hetrocyclic aryl sulphonamidesBAYER HEALTHCARE AG·Filed 2002·Granted Oct 3, 2006·4 cites·13 claims
- 1866US10576064B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Mar 3, 2020·1 cites·10 claims
- 1964US8343981B2Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agentsAICURIS GMBH & CO KG·Filed 2004·Granted Jan 1, 2013·2 cites·23 claims
- 2063US12064421B2Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Aug 20, 2024·0 cites·23 claims
- 2162US12060367B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Granted Aug 13, 2024·0 cites·49 claims
- 2262US2025002504A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2361US2025019385A1Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2460US2025382288A18-aza quinazolines as brain-penetrant sos1-inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2559US11814380B2Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Nov 14, 2023·0 cites·14 claims
- 2656US2023227470A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2755US6756489B1Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing sameAVENTIS PHARMA GMBH·Filed 1998·Granted Jun 29, 2004·13 cites·2 claims
- 2854US2025296940A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 2954US2025129095A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 3049US2018291030A1New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3149US2011015241A1Substituted heterocycles and use thereofBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 3243US8263624B2Aryl-substituted heterocycles, and use thereofHAERTER MICHAEL·Filed 2007·Granted Sep 11, 2012·0 cites·14 claims
- 3339US2007099929A1Substituted thiophenesAICURIS GMBH & CO KG·Filed 2006·Application pending·0 cites
- 3438US2005059658A1PyridazinoneFiled 2002·Application pending·0 cites
- 3538US2007004735A1Method for inhibiting the replication of herpes virusesBETZ ULRICH·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tobias Wunberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →